Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin
Bindu Chamarthi, Anthony H. Cincotta
Postgraduate Medicine (2017) Vol. 129, Iss. 4, pp. 446-455
Open Access | Times Cited: 24

Showing 24 citing articles:

Neuroprotective strategies for retinal disease
Machelle T. Pardue, Rachael S Allen
Progress in Retinal and Eye Research (2018) Vol. 65, pp. 50-76
Open Access | Times Cited: 202
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho
Parkinson s Disease (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 56
Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes
G. Tavares, Daniela Marques, Cátia Barra, et al.
Molecular Metabolism (2021) Vol. 51, pp. 101241-101241
Open Access | Times Cited: 49
Bromocriptine therapy: Review of mechanism of action, safety and tolerability
Faiza Naz, Abdul Malik, Muhammad Riaz, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 8, pp. 903-922
Closed Access | Times Cited: 29
Circadian Dysfunction in Adipose Tissue: Chronotherapy in Metabolic Diseases
Erkan Civelek, Dilek Öztürk Civelek, Yasemin Kübra Akyel, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1077-1077
Open Access | Times Cited: 16
The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials
Ida Brandt Andersen, Mikkel Andreassen, Jesper Krogh
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 1, pp. 58-67
Closed Access | Times Cited: 22
Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities
Mohd Faizan, Alika Sarkar, Mahendra Pratap Singh
Ageing Research Reviews (2022) Vol. 81, pp. 101727-101727
Closed Access | Times Cited: 11
Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism
Chih‐Neng Hsu, Chin‐Feng Hsuan, Daniel Liao, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1024-1024
Open Access | Times Cited: 6
Dopamine 2 agonists for the management of type 2 diabetes: a systematic review and meta-analysis
Beyene Dereje, Aschalew Nardos
Journal of Diabetes & Metabolic Disorders (2023) Vol. 22, Iss. 2, pp. 931-943
Open Access | Times Cited: 6
Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects
Anthony H. Cincotta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13255-13255
Open Access | Times Cited: 6
Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses
C.M.M. Loos, Kristine L. Urschel, E.S. Vanzant, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 10
Probing the characteristics and biofunctional effects of disease-affected cells and drug response via machine learning applications
Deborah Mudali, Jaison Jeevanandam, Michael K. Danquah
Critical Reviews in Biotechnology (2020) Vol. 40, Iss. 7, pp. 951-977
Closed Access | Times Cited: 10
Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review
Mulualem Tesfaye Birhan, Teklie Mengie Ayele, Fikire Wondimu Abebe, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 3
New Medications for the Treatment of Diabetes
Satish K. Garg, Amanda Rewers, Halis Kaan Aktürk
Diabetes Technology & Therapeutics (2018) Vol. 20, Iss. S1, pp. S-153
Open Access | Times Cited: 7
Oral antidiabetic agents: Recently available novel oral antidiabetic agents in India: A clinical review
Nitin Kapoor, Nihal Thomas
Current Medical Issues (2017) Vol. 15, Iss. 3, pp. 169-169
Open Access | Times Cited: 7
Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus
Maka Siamashvili, Stephen N. Davis
Expert Opinion on Pharmacotherapy (2020) Vol. 22, Iss. 2, pp. 241-247
Closed Access | Times Cited: 5
Efficacy and Safety of Bromocriptine-QR as an Adjunctive Therapy on Glycemic Control in Subjects with Uncontrolled Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Theo Audi Yanto, Charista Lydia Budiputri, Michelle Patricia Muljono, et al.
Journal of the ASEAN Federation of Endocrine Societies (2024) Vol. 39, Iss. 1, pp. 95-105
Open Access
A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents
Bantayehu Addis Tegegne, Adane Adugna, Aderaw Yenet, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Bromocriptine and Colesevelam Hydrochloride: Novel Therapies for Type II Diabetes Mellitus
Lenise G. Soileau, Angela Nguyen, A.N. Senthil, et al.
Cureus (2023)
Open Access | Times Cited: 1
Current Views on Dopaminergic Drugs Affecting Glucose Homeostasis
Mortaza Fatehi Hassanabad, Mohammad Fatehi
Current Diabetes Reviews (2018) Vol. 15, Iss. 2, pp. 93-99
Closed Access | Times Cited: 2
Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus
Alfredo Briones-Aranda, Javier Ramírez-Carballo, Bernardo Alfredo Romero Gómez, et al.
Romanian Journal of Diabetes Nutrition and Metabolic Diseases (2018) Vol. 25, Iss. 1, pp. 59-66
Open Access | Times Cited: 1
Peripheral and central serotonin in the regulation of glucose metabolism
Mireille J. Serlie
Handbook of behavioral neuroscience (2020), pp. 893-900
Closed Access | Times Cited: 1
Select medications that unexpectedly lower HbA1c levels
Frank Tillman, J Kim
Journal of Clinical Pharmacy and Therapeutics (2018) Vol. 43, Iss. 4, pp. 587-590
Open Access
Impact of Initiation of Insulin Therapy on Serum Prolactin and Cortisol Levels in Type 2 Diabetic Male Patients
Hany Khairy Mansour, Mohamed Saad Hamed, Alyaa Ahmed El Sherbeny, et al.
The Egyptian Journal of Hospital Medicine (2022) Vol. 88, Iss. 1, pp. 3952-3958
Open Access
Page 1

Scroll to top